New FDA Guidance Provides Details on Diversity Action Plans for Clinical Studies
Posted | July 9, 2024FDA Guidance Summary The U.S. Food and Drug Administration (FDA) has issued a draft guidance titled “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies.”…